Achyranthes aspera ameliorates stress induced depression in mice by regulating neuroinflammatory cytokines

10.1016/j.jtcme.2022.06.001

Dinesh Gawande；Samiksha Barewar；Jayshree Taksande；Milind Umekar；Balu Ghule；Brijesh Taksande；Nandkishor Kotagale

Achyranthes aspera ； Depression ； Anhedonia ； CUMS ； BDNF ； Neuro-inflammation

Journal of Traditional and Complementary Medicine

12卷6期（2022 / 11 / 01）

545 - 555

英文

Background and aim: Achyranthes aspera Linn. (A. aspera) (family: Amaranthaceae) is highly recognized in ethnomedicine and traditional systems of Indian medicine as a nervine restorative for several psychiatric disorders. Study presented here was designed to appraise the antidepressant-like effects of A. aspera in murine model of chronic unpredictable mild stress (CUMS) induced depression. Experimental procedures-: Rodents were exposed to different stressor in unpredictive manner during CUMS protocol once a day for 4 weeks. Mice were intraperitoneally injected with A. aspera extract (2.5, 5 and 10 mg/kg) or fluoxetine (10 mg/kg) or betaine (20 mg/kg) once daily during day 15-28 of the CUMS protocol. Sucrose preference, motivation and self-care, immobility latency and plasma corticosterone were evaluated after 24 h of last stressor. After behavioral assessments TNF-α, Il-6 and BDNF immunocontent was determined in hippocampus and prefrontal cortex. Results and conclusion: A. aspera extract as well as betaine improved sucrose preference, increased grooming frequency and latency in splash test and ameliorated depression-like condition in CUMS mice in Porsolt test. A. aspera treatment decreased the elevated plasma corticosterone and reversed the effect of CUMS on TNF-α, Il-6 and BDNF immunocontent in mice. The results of the present study suggest A. aspera as a promising indigenous medicine for stress associated neurobehavioral and comorbid complications.

1. Aboul-Fotouh, S(2015).Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and mono-aminergic neurotransmitters.Psychopharmacology,232(6),1095-1105.
2. Akbar, S(2020).Handbook of 200 Medicinal Plants- A Comprehensive Review of Their Traditional Medical Uses and Scientific Justifications.Switzerland AG:Springer Nature.
3. Almeida, IB,Gomes, IA,Shanmugam, S(2020).Inflammatory modulation of fluoxetine use in patients with depression: a systematic review and meta-analysis.Cytokine,131,155100.
4. Barua, CC,Talukdar, A,Begum, SA(2009).Antidepressant-like effects of the methanol extract of Achyranthes aspera Linn. in animal models of depression.Pharmacologyonline,2,587-594.
5. Barua, CC,Talukdar, A,Begum, SA(2012).Anxiolytic activity of methanol leaf extract of Achyranthes aspera Linn in mice using experimental models of anxiety.Indian J Pharmacol,44,63-67.
6. Brunoni, AR,Lopes, M,Fregni, F(2008).A systematic review and metaanalysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.Int J Neuropsychopharmacol,11,1169-1180.
7. David, DJ,Gourion, D(2016).Antidepressant and tolerance: determinants and management of major side effects.Encephale,42(6),553-561.
8. Dey, A,Hankey-Giblin, PA(2018).Insights into macrophage heterogeneity and cytokine-induced neuroinflammation in major depressive disorder.Pharmaceuticals,11(3),64.
9. Ducottet, C,Belzung, C.(2004).Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice.Physiol Behav,81,417-426.
10. Ducottet, C,Griebel, G,Belzung, C(2003).Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice.Prog Neuro-Psychopharmacol Biol Psychiatry,27,625-631.
11. Duman, RS,Aghajanian, GK(2012).Synaptic dysfunction in depression: potential therapeutic targets.Science.,338,68-72.
12. Dwivedi, S,Dubey, R,Mehta, K(2008).Achyranthes aspera Linn. (Chirchira): a magic herb in folk medicine.Ethnobot Leafl,12,670-676.
13. Edwin, S,Edwin, JE,Deb, L(2008).Wound healing and antioxidant activity of Achyranthes aspera.Pharm Biol,46(12),824-828.
14. Gawande, DY,Druzhilovsky, D,Gupta, RC(2017).Anticonvulsant activity and acute neurotoxic profile of Achyranthes aspera Linn.J Ethnopharmacol,202,97-102.
15. Gawande, DY,Goel, RK(2015).Pharmacological validation of in-silico guided novel nootropic potential of Achyranthes aspera L.J Ethnopharmacol,175,324-334.
16. Gervasoni, N,Aubry, JM,Bondolfi, G(2005).Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode.Neuropsychobiology,51,234-238.
17. Gokhale, AB,Damre, AS,Kulkarni, KR(2002).Preliminary evaluation of antiinflammatory and anti-arthritic activity of S. lappa, A. speciosa and A. aspera.Phytomedicine,9(5),433-437.
18. Harborne, JB(1984).Phytochemical Methods - a Guide to Modern Techniques of Plant Analysis.New York:Chapmann and Hall.
19. Huang, X,Mao, YS,Li, C(2014).Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.Int J Clin Exp Pathol,7(8),4577-4586.
20. Iwata, M,Ota, KT,Duman, RS(2013).The inflammasome: pathways linking psychological stress, depression, and systemic illnesses.Brain Behav Immun,31,105-114.
21. Jaiswal, Y,Liang, Z,Ho, A(2018).Tissue based metabolite profiling and qualitative comparison of two species of Achyranthes roots by use of UHPLC-QTOF MS and laser micro dissection.J Pharm Anal,8(1),110-19.
22. Jiang, P,Zhang, WY,Li, HD(2013).Stress and vitamin D: altered vitamin D metabolism in both the hippocampus and myocardium of chronic unpredictable mild stress exposed rats.Psychoneuroendocrinology,38(10),2091-2098.
23. Jindal, A,Mahesh, R,Bhatt, S(2013).Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage.Pharmacol Biochem Behav,105,63-70.
24. Kapoor, VK,Singh, H.(1996).Isolation of betaine from Achyranthes aspera Linn.Indian J Chem,4(10),461-463.
25. Karege, F,Vaudan, G,Schwald, M(2005).Neurotrophin levels in post mortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.Mol Brain Res.,136,29-37.
26. Katz, RJ(1982).Animal model of depression: pharmacological sensitivity of a hedonic deficit.Pharmacol Biochem Behav,16(6),965-968.
27. Khandagle, AJ,Tare, VS,Raut, KD(2011).Bioactivity of essential oils of Zingiber officinalis and Achyranthes aspera against mosquitoes.Parasitol Res,109,339-343.
28. Khurana, RN,Baudendistel, TE(2003).Hypertensive crisis associated with venlafaxine.Am J Med.,115,676-677.
29. Kiritikar, KR,Basu, BD.(1981).Indian Medicinal Plants.India:International Book Publishers.
30. Kumar, V(2006).Potential medicinal plants for CNS disorders: an overview.Phytother Res,20,1023-1035.
31. Kunisawa, K,Kido, K,Nakashima, N(2017).Betaine attenuates memory impairment after water-immersion restraint stress and is regulated by the GABAergic neuronal system in the hippocampus.Eur J Pharmacol,796,122-130.
32. Lai, CH(2019).The neural markers of MRI to differentiate depression and panic disorder.Prog Neuro-Psychopharmacol Biol Psychiatry,91,72-78.
33. Lavergne, F,Jay, TM(2010).A new strategy for antidepressant prescription.Front Neurosci,4,192.
34. Lee, JO,Yang, WS,Park, JG(2017).Src and Syk contribute to the anti-inflammatory activities of Achyranthes aspera ethanolic extract.J Ethnopharmacol,206,1-7.
35. Li, G,Jing, P,Liu, Z(2017).Beneficial effect of fluoxetine treatment against psychological stress is mediated by increasing BDNF expression in selected brain areas.Oncotarget,8(41),69527-69537.
36. Li, S,Wang, C,Wang, M(2007).Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms.Life Sci.,80,1373-1381.
37. Liu, W,Ge, T,Leng, Y(2017).The role of neural plasticity in depression: from Hippocampus to prefrontal cortex.Neural Plast,6871089.
38. Liu, Y,Jia, G,Gou, L(2013).Antidepressant-like effects of tea polyphenols on mouse model of chronic unpredictable mild stress.Pharmacol Biochem Behav,104,27-32.
39. McCarty, MF,O'Keefe, JH,DiNicolantonio, JJ(2019).A diet rich in taurine, cysteine, folate, B(12) and betaine may lessen risk for Alzheimer's disease by boosting brain synthesis of hydrogen sulfide.Med Hypotheses,132,109356.
40. Mehta, F,Patel, BG,Pandya, SS(2011).High-performance thin-layer chromatographic analysis of betaine in alcohol extracts of Achyranthes aspera L.J Planar Chromatogr,24,136-139.
41. Nadkarni, KM(2009).Indian materia medica.Bombay Popular Prakashan,1,21.
42. Ohnishi, T,Balan, S,Toyoshima, M(2019).Investigation of betaine as a novel psychotherapeutic for schizophrenia.Biomedicine,45,432-446.
43. Porsolt, RD,Bertin, A,Jalfre, M(1977).Behavioral despair in mice: a primary screening test for antidepressants.Arch Int Pharmacodyn Ther,229(2),327-336.
44. Rush, G,O'Donovan, A,Nagle, L(2016).Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.J Affect Disord,205,60-68.
45. Sharma, J,Gairola, S,Gaur, RD(2013).Ethnomedicinal plants used for treating epilepsy by indigenous communities of sub-Himalayan region of Uttarakhand, India.J Ethnopharmacol,150(1),353-370.
46. Shi, H,Wang, XL,Quan, HF(2019).Effects of betaine on LPS-stimulated activation of microglial M1/M2 phenotypes by suppressing TLR4/NF-κB pathways in N9 cells.Molecules,24(2),367.
47. Taksande, BG,Faldu, DS,Dixit, MP(2013).Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice.Eur J Pharmacol,720(1-3),115-120.
48. Trease, GE,Evans, WC.(2008).Pharmacognosy.London:WB Saunders.
49. Vijaya Kumar, S,Sankar, P,Varatharajan, R(2009).Anti-inflammatory activity of roots of Achyranthes Aspera.Pharm Biol,47(10),973-975.
50. Viswanatha, GL,Venkataranganna, MV,Lingeswara Prasad, NB(2019).Achyranthes aspera Linn. alleviates cerebral ischemia-reperfusion induced neurocognitive, biochemical, morphological and histological alterations in Wistar rats.J Ethnopharmacol,228,58-69.
51. Wang, D,An, SC,Zhang, X(2008).Prevention of chronic stress-induced depression-like behaviour by inducible nitric oxide inhibitor.Neurosci Lett,433,59-64.
52. Willner, P(1997).Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation.Psychopharmacology,134(4),319-329.
53. Willner, P,Towell, A,Sampson, D(1987).Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antide-pressant.Psychopharmacology,93,358-364.
54. YalcinI, Aksu, F,Belzung, C(2005).Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol.Eur J Pharmacol,514(2-3),165-174.
55. Zhu, L,Chen, T,Chang, X(2016).Salidroside ameliorates arthritis-induced brain cognition deficits by regulating Rho/ROCK/NF-kB pathway.Neuropharmacology,103,134-142.